Sonoma Pharmaceuticals, Inc. announced its financial results for the second fiscal quarter ended September 30, 2024, on November 7, 2024. The company reported a 31% increase in revenue for the quarter compared to the same period in the prior year.
The company achieved positive cash flows from operations of $0.35 million for the quarter, marking a significant operational milestone. Furthermore, the net loss improved by 59% for the quarter compared to the prior year period.
Net loss per share also saw a substantial improvement, decreasing by 90% for the quarter compared to the same period last year. These results reflect diligent efforts to grow the business and drive towards profitability.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.